Clarity Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Jul '25 Jul 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019 - 2020
Market Capitalization	1,070	1,127	121	91	-	-	Upgrade
Market Cap Growth	143.75%	828.01%	33.99%	-	-	-	Upgrade
Enterprise Value	999	1,102	71	24	-	-	Upgrade
Last Close Price	2.95	3.73	0.49	-	-	-	Upgrade
PS Ratio	160.49	146.79	18.62	20.37	-	-	Upgrade
PB Ratio	13.58	11.55	2.64	1.43	-	-	Upgrade
P/TBV Ratio	13.58	11.55	2.64	1.43	-	-	Upgrade
EV/Sales Ratio	143.59	143.49	10.87	5.40	-	-	Upgrade
Asset Turnover	0.11	0.10	0.11	0.11	0.20	0.29	Upgrade
Quick Ratio	13.74	18.44	9.95	13.19	9.91	9.43	Upgrade
Current Ratio	14.55	19.05	10.17	13.26	10.00	9.56	Upgrade
Return on Equity (ROE)	-53.99%	-39.28%	-30.48%	-42.23%	-71.89%	-80.00%	Upgrade
Return on Assets (ROA)	-36.11%	-24.19%	-18.65%	-17.41%	-40.63%	-45.29%	Upgrade
Return on Capital (ROIC)	-39.07%	-25.99%	-20.42%	-18.94%	-45.34%	-50.74%	Upgrade
Earnings Yield	-2.82%	-2.51%	-13.48%	-18.06%	-	-	Upgrade
FCF Yield	-2.72%	-2.59%	-15.10%	-10.28%	-	-	Upgrade
Buyback Yield / Dilution	-15.21%	-5.22%	-4.81%	-40.37%	-20.54%	-2.86%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.